Company Summary
Search
Home Page
 
BioSyent Inc. 
Listed Company 
Current   Past  
Fiscal Year EndCompany StatusExempt Flag
December 31TradingN
Board of Directors
NamePosition
Douglas R. Larson  Director of the Board
  Secretary of the Board
Milton E. Wakefield  Director of the Board
Paul R. Montador  Director of the Board
Peter Lockhard  Director of the Board
Rene C. Goehrum  President
  Chairperson of the Board
Incorporation Locations
Inc. DateExpiry DateCountryRegionDescription
28/Apr/1947  Canada   
Exchange Filing Office
Location
Vancouver Regional Service Office
Business Type(s)
Primary/SecondaryBusiness TypeDetails
Primary  Pharmaceutical Manufacturer and Distributor  BioSyent Inc. is a publicly traded specialty pharmaceutical company whose wholly owned subsidiary, BioSyent Pharma Inc., sources, acquires or in-licences pharmaceutical products and markets these products in Canada. Wholly owned BioSyent subsidiary Hedley Technologies Ltd. operates the company's legacy business marketing bio and health friendly non-chemical insecticides. BioSyent common shares are listed for trading on the TSX Venture Exchange (TSXV) under the symbol RX.  
Securities
SymbolSecurity NameMarketStatus
RXBioSyent Inc.TSX VentureTRADING
Name HistoryFromTo
BioSyent Inc.13/Jun/2006Present
Company Facts Reconciliation
SubjectDate Returned
Summer 2013 CFR20/Jun/2013
Associations
Auditing Firm:  Meyers Norris Penny LLP
Investor Relations:  Rene Goehrum
Law Firm:  Miller Thomson LLP
Subsidiary:  Hedley Technologies USA Inc.
  BioSyent Pharma Inc.
  Hedley Technologies Ltd.
Transfer Agent:  Computershare Investor Services Inc.
Latest Information
TypeDateTitle
News Releases  21/Aug/2014  NEWS RELEASE - BIOSYENT RELEASES Q2 AND SIX MONTH RESULTS-Q2 SALES INCREASE 72% NET INCOME AFTER TAX UP 112%[MARKETWIRE]
    NEWS RELEASE - RELEASES Q2 AND SIX MONTH RESULTS Q2 SALES INCRE[MARKET NEWS]
    NEWS RELEASE - BIOSYENT PHARMA SIGNS EXCLUSIVE LICENSING AND DISTRIBUTION AGREEMENT FOR NEW URGENT CARE DRUG PRODUCT[MARKETWIRE]
Bulletins  12/Jun/2006  Name Change
Meetings and Public Filings  Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations
Location Name: Head Office Area Name: Mississauga 
Effective Date: 23/Apr/1998 Location Ownership Percent: 100 
Expiry Date:  Phone: (905) 206-0013 (primary)
Address: 2601 Matheson Blvd. E. Suite 5
Mississauga,Ontario
Canada L4W 5A8
North America
Fax: (905) 206-1413 (primary)
Description:  

* Historical Data